Shared decision-making in breast cancer: Discrepancy between the treatment efficacy required by patients and by physicians

Breast Cancer Research and Treatment

Volumn 135, Issue 3, 2012, Pages 811-820

  Thiel, Falk C ^a,b   Schrauder, Michael G ^a,b   Fasching, Peter A ^a,b   Löhberg, Christian R ^a,b   Bani, Mayada R ^a,b   Häberle, Lothar ^a,b   Tänzer, Thorsten ^a,b   Radosavac, Dragan ^a,b   Scharl, Anton ^c   Bauerfeind, Ingo ^d   Gesslein, Judith ^e   Schulte, Hilde ^f   Overbeck Schulte, Brigitte ^f   Beckmann, Matthias W ^a,b   Lux, Michael P ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Friedrich Alexander University Erlangen Nuremberg   (Germany)

^c St Marien Hospital   (Germany)

^d Hospital Landshut   (Germany)

^e Nuremberg Hospital   (Germany)

^f Frauenselbsthilfe Nach Krebs EV   (Germany)

Author keywords

Adjuvant therapy; Benefit; Breast cancer; Perception of risk; Shared decision making

Indexed keywords

ANTIBODY;

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CONTROLLED STUDY; EXPECTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL HISTORY; PATIENT ATTITUDE; PATIENT INFORMATION; PERSONAL EXPERIENCE; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SPECIALIZATION; WORK ENVIRONMENT;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PHYSICIANS; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84866525301     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-012-2218-y     Document Type: Article

References (37)

1. Brody DS (1980) The patient's role in clinical decision-making. Ann Intern Med 93:718-722 (Pubitemid 10030296)
2. Bruera E, Willey JS, Palmer JL, Rosales M (2002) Treatment decisions for breast carcinoma: patient preferences and physician perceptions. Cancer 94:2076-2080 (Pubitemid 34270063)
3. Deber RB, Kraetschmer N, Urowitz S, Sharpe N (2007) Do people want to be autonomous patients? Preferred roles in treatment decision-making in several patient populations. Health Expect 10:248-258 (Pubitemid 47196353)
4. Keating NL, Beth Landrum M, Arora NK, Malin JL, Ganz PA, van Ryn M, Weeks JC (2010) Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? J Clin Oncol 28:4364-4370
5. Silliman RA, Dukes KA, Sullivan LM, Kaplan SH (1998) Breast cancer care in older women: sources of information, social support, and emotional health outcomes. Cancer 83:706-711 (Pubitemid 28387693)
6. Degner LF, Kristjanson LJ, Bowman D, Sloan JA, Carriere KC, O'Neil J, Bilodeau B, Watson P, Mueller B (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277:1485-1492 (Pubitemid 27208893)
7. Vogel BA, Bengel J, Helmes AW (2008) Information and decision making: patients' needs and experiences in the course of breast cancer treatment. Patient Educ Couns 71:79-85
8. Arora NK, McHorney CA (2000) Patient preferences for medical decision making: who really wants to participate? Med Care 38:335-341
9. Huober J, Thurlimann B (2009) Adjuvant! When the new world meets the old world. Lancet Oncol 10:1028-1029
10. Pieterse AH, Baas-Thijssen MC, Marijnen CA, Stiggelbout AM (2008) Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration. Br J Cancer 99:875-882
11. Langer AS (2001) Side effects, quality-of-life issues, and tradeoffs: the patient perspective. J Natl Cancer Inst Monogr 30: 125-129
12. Siminoff LA, Fetting JH, Abeloff MD (1989) Doctor-patient communication about breast cancer adjuvant therapy. J Clin Oncol 7:1192-1200 (Pubitemid 19220120)
13. Ravdin PM, Siminoff IA, Harvey JA (1998) Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 16:515-521 (Pubitemid 28135593)
14. Klemperer D, Rosenwirth M (2005) Shared decision making: Konzept, Voraussetzung und politische Implikationen. Chartbook, 2nd edition, Bertelsmann Stiftung, Gütersloh, Germany
15. Stalmeier PF, van Tol-Geerdink JJ, van Lin EN, Schimmel E, Huizenga H, van Daal WA, Leer JW (2007) Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy. J Clin Oncol 25:3096-3100 (Pubitemid 47218057)
16. Cotler SJ, Patil R, McNutt RA, Speroff T, Banaad-Omiotek G, Ganger DR, Rosenblate H, Kaur S, Cotler S, Jensen DM (2001) Patients' values for health states associated with hepatitis C and physicians' estimates of those values. Am J Gastroenterol 96:2730-2736
17. Renfroe EG, Heywood G, Foreman L, Schron E, Powell J, Baessler C, Warwick D, Morris M, Hallstrom A (2002) The endof-study patient survey: methods influencing response rate in the AVID Trial. Control Clin Trials 23:521-533 (Pubitemid 35232394)
18. Matsuda T, Marche H, Grosclaude P, Clement S (2004) Participation behaviour of bladder cancer survivors in a medical followup survey on quality of life in France. Eur J Epidemiol 19: 313-321 (Pubitemid 39005430)
19. Angus VC, Entwistle VA, Emslie MJ, Walker KA, Andrew JE (2003) The requirement for prior consent to participate on survey response rates: a population-based survey in Grampian. BMC Health Serv Res 3:21
20. Jepson C, Asch DA, Hershey JC, Ubel PA (2005) In a mailed physician survey, questionnaire length had a threshold effect on response rate. J Clin Epidemiol 58:103-105 (Pubitemid 40093119)
21. Slevin ML, Stubbs L, Plant HJ, Wilson P, Gregory WM, Armes PJ, Downer SM (1990) Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ 300:1458-1460 (Pubitemid 20195333)
22. Duric VM, Butow PN, Sharpe L, Heritier S, Boyle F, Beith J, Wilcken NR, Coates AS, Simes RJ, Stockler MR (2008) Comparing patients' and their partners' preferences for adjuvant chemotherapy in early breast cancer. Patient Educ Couns 72:239-245
23. Simes RJ, Coates AS (2001) Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? J Natl Cancer Inst Monogr 30:146-152
24. Duric VM, Stockler MR, Heritier S, Boyle F, Beith J, Sullivan A, Wilcken N, Coates AS, Simes RJ (2005) Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? Ann Oncol 16:1786-1794 (Pubitemid 41631241)
25. Thewes B, Meiser B, Duric VM, Stockler MR, Taylor A, Stuart-Harris R, Links M, Wilcken N, McLachlan SA, Phillips KA et al (2005) What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile? Lancet Oncol 6:581-588 (Pubitemid 41051936)
26. Duric VM, Fallowfield LJ, Saunders C, Houghton J, Coates AS, Stockler MR (2005) Patients' preferences for adjuvant endocrine therapy in early breast cancer: what makes it worthwhile? Br J Cancer 93:1319-1323 (Pubitemid 41752856)
27. McMenamin M, Barry H, Lennon AM, Purcell H, Baum M, Keegan D, McDermott E, O'Donoghue D, Daly L, Mulcahy H (2005) A survey of breast cancer awareness and knowledge in a Western population: lots of light but little illumination. Eur J Cancer 41:393-397 (Pubitemid 40187210)
28. Takakuwa KM, Ernst AA, Weiss SJ, Nick TG (2000) Breast cancer knowledge and preventive behaviours: an urban emergency department-based survey. Acad Emerg Med 7:1393-1398
29. Wallberg B, Michelson H, Nystedt M, Bolund C, Degner LF, Wilking N (2000) Information needs and preferences for participation in treatment decisions among Swedish breast cancer patients. Acta Oncol 39:467-476
30. Mandelblatt J, Kreling B, Figeuriedo M, Feng S (2006) What is the impact of shared decision making on treatment and outcomes for older women with breast cancer? J Clin Oncol 24:4908-4913 (Pubitemid 46630919)
31. Duric VM, Butow PN, Sharpe L, Boyle F, Beith J, Wilcken NR, Heritier S, Coates AS, John Simes R, Stockler MR (2007) Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer. Psychooncology 16:48-59 (Pubitemid 46189077)
32. Street RL Jr (1992) Analyzing communication in medical consultations. Do behavioral measures correspond to patients' perceptions? Med Care 30:976-988
33. Mook S, Schmidt MK, Rutgers EJ, van de Velde AO, Visser O, Rutgers SM, Armstrong N, van't Veer LJ, Ravdin PM (2009) Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospitalbased retrospective cohort study. Lancet Oncol 10:1070-1076
34. Agarwal V, O'Neill P (2010) Adjuvant! Online as a decisionmaking tool in early breast cancer-a UK National Survey. Clin Oncol (R Coll Radiol) 23:159-160
35. Nowak V, Ah-See M, Ravichandran D (2010) Breast cancer multidisciplinary team adjuvant therapy decision making and adjuvant! Online. Clin Oncol (R Coll Radiol) 22:87-88
36. Fasching PA, Ekici AB, Adamietz BR, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Jud SM, Heusinger K, Rubner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW (2011) Breast cancer risk: genes, environment and clinics. Geburtsh Frauenheilk 71:1056-1066
37. Lux MP, Fasching PA, Löhberg CR, Jud SM, Schrauder MG, Bani MR, Thiel FC, Hack CC, Hildebrandt T, Beckmann MW (2011) Health Services Research and Health Economy -Quality Care Training in Gynaecology, with Focus on Gynaecological Oncology. Geburtsh Frauenheilk 71:1046-1055